---
title: "Sage Therap (SAGE.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/SAGE.US.md"
symbol: "SAGE.US"
name: "Sage Therap"
industry: "生物技术"
---

# Sage Therap (SAGE.US)

| Item | Detail |
|------|--------|
| Industry | 生物技术 |

## Company Profile

Sage Therapeutics, Inc.是一家生物制药公司，专注于开发和商业化脑健康药物。该公司提供 ZURZUVAE，这是一种神经活性类固醇，作为 GABA 受体的正向变构调节剂，针对突触和突触外 GABA 受体，用于治疗成人产后抑郁症。其产品管线还包括 SAGE-324，这是一种新型 GABA 受体正向变构调节剂，适用于慢性口服给药，包括治疗发育性和癫痫性脑病中的癫痫发作；以及 SAGE-319，一种偏好突触外 GABA 受体的正向变构调节剂，用于治疗与神经发育障碍相关的行为症状。此外，该公司还在开发多种产品候选药物，包括 SAGE-817 和 SAGE-039，用于治疗急性和慢性脑...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -1.80 | 283/604 | - | - | - |
| PB | 1.47 | 178/604 | 1.47 | 1.47 | 1.03 |
| PS (TTM) | 7.72 | 171/604 | 11.36 | 7.72 | 7.72 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 8.68 |

## References

- [Company Overview](https://longbridge.com/en/quote/SAGE.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/SAGE.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/SAGE.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.